Small Left Ventricular Size Is an Independent Risk Factor for Ventricular Assist Device Thrombosis

被引:37
|
作者
Chivukula, Venkat Keshav [1 ]
Beckman, Jennifer A. [2 ]
Prisco, Anthony R. [3 ]
Lin, Shin [2 ]
Dardas, Todd F. [2 ]
Cheng, Richard K. [2 ]
Farris, Stephen D. [2 ]
Smith, Jason W. [4 ]
Mokadam, Nahush A. [4 ]
Mahr, Claudius [2 ]
Aliseda, Alberto [1 ]
机构
[1] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA
[2] Univ Washington, Div Cardiol, Seattle, WA 98195 USA
[3] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA
[4] Univ Washington, Div Cardiothorac Surg, Seattle, WA 98195 USA
关键词
left ventricular assist device; mechanical circulatory support; left ventricle size; thrombogenic potential; hemodynamics; Lagrangian metrics; computational fluid dynamics; virtual surgery; shear stress history; residence time; BODY-SURFACE-AREA; CONTINUOUS-FLOW; HEART-FAILURE; PUMP; LVAD; ACTIVATION; MANAGEMENT; OUTCOMES;
D O I
10.1097/MAT.0000000000000798
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The prevalence of ventricular assist device (VAD) therapy has continued to increase due to a stagnant donor supply and growing advanced heart failure (HF) population. We hypothesize that left ventricular (LV) size strongly influences biocompatibility and risk of thrombosis. Unsteady computational fluid dynamics (CFD) was used in conjunction with patient-derived computational modeling and virtual surgery with a standard, apically implanted inflow cannula. A dual-focus approach of evaluating thrombogenicity was employed: platelet-based metrics to characterize the platelet environment and flow-based metrics to investigate hemodynamics. Left ventricular end-diastolic dimensions (LVEDds) ranging from 4.5 to 6.5 cm were studied and ranked according to relative thrombogenic potential. Over 150,000 platelets were individually tracked in each LV model over 15 cardiac cycles. As LV size decreased, platelets experienced markedly increased shear stress histories (SHs), whereas platelet residence time (RT) in the LV increased with size. The complex interplay between increased SH and longer RT has profound implications on thrombogenicity, with a significantly higher proportion of platelets in small LVs having long RT times and being subjected to high SH, contributing to thrombus formation. Our data suggest that small LV size, rather than decreased VAD speed, is the primary pathologic mechanism responsible for the increased incidence of thrombosis observed in VAD patients with small LVs.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 50 条
  • [21] Aspirin resistance: A role in left ventricular assist device thrombosis?
    DeNino, Walter F.
    Floroff, Catherine
    Uber, Walter E.
    Ikonomidis, John S.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 150 (06): : E97 - E98
  • [22] A Stepwise Approach to Left Ventricular Assist Device Pump Thrombosis
    Kocabeyoglu, Sinan Sabit
    Kervan, Umit
    Sert, Dogan Emre
    Karahan, Mehmet
    Unal, Ertekin Utku
    Catav, Zeki
    Pac, Mustafa
    HEART LUNG AND CIRCULATION, 2021, 30 (04): : 567 - 576
  • [23] Left Ventricular Assist Device Thrombosis Another Piece of the Puzzle?
    Lindenfeld, JoAnn
    Keebler, Mary E.
    JACC-HEART FAILURE, 2015, 3 (02) : 154 - 158
  • [24] Baseline Thromboelastogram as a Predictor of Left Ventricular Assist Device Thrombosis
    Piche, Shannon L.
    Nei, Scott D.
    Frazee, Erin
    Schettle, Sarah D.
    Boilson, Barry A.
    Plevak, Matthew F.
    Dierkhising, Ross A.
    Stulak, John M.
    ASAIO JOURNAL, 2019, 65 (05) : 443 - 448
  • [25] Unexpected Abrupt Increase in Left Ventricular Assist Device Thrombosis
    Starling, Randall C.
    Moazami, Nader
    Silvestry, Scott C.
    Ewald, Gregory
    Rogers, Joseph G.
    Milano, Carmelo A.
    Rame, J. Eduardo
    Acker, Michael A.
    Blackstone, Eugene H.
    Ehrlinger, John
    Thuita, Lucy
    Mountis, Maria M.
    Soltesz, Edward G.
    Lytle, Bruce W.
    Smedira, Nicholas G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (01): : 33 - 40
  • [26] Unexpected Abrupt Increase in Left Ventricular Assist Device Thrombosis
    Rame, J. Eduardo
    Atluri, Pavan
    Acker, Michael A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15): : 1466 - 1467
  • [27] Tirofiban in Suspected Left Ventricular Assist Device Pump Thrombosis
    Nei, Scott D.
    Wieruszewski, Patrick M.
    Orzel, Libby A.
    Ritchie, Brianne M.
    Stulak, John M.
    ASAIO JOURNAL, 2020, 66 (08) : 886 - 889
  • [28] BASELINE THROMBOELASTOGRAM AS A PREDICTOR OF LEFT VENTRICULAR ASSIST DEVICE THROMBOSIS
    Piche, Shannon
    Nei, Scott
    Frazee, Erin
    Schettle, Sarah
    Boilson, Barry
    Dierkhising, Ross
    Stulak, John
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [29] Platelet Inhibition With Ticagrelor for Left Ventricular Assist Device Thrombosis
    Oliveira, Guilherme H.
    Al-Kindi, Sadeer G.
    ElAmm, Chantal
    Qattan, Marwan Y.
    Deo, Salil
    Medalion, Benjamin
    Benatti, Rodolfo D.
    Osman, Mohamed N.
    Ginwalla, Mahazarin
    Park, Soon J.
    Simon, Daniel I.
    CIRCULATION-HEART FAILURE, 2015, 8 (03) : 649 - 651
  • [30] Ventricular arrhythmias and left ventricular assist device
    Ozcan, Cevher
    Barrett, Conor D.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : E81 - E83